Literature DB >> 13982509

Quinidine therapy of chronic auricular fibrillation. The occurrence and mechanism of syncope.

R ROKSETH, O STORSTEIN.   

Abstract

Entities:  

Keywords:  AURICULAR FIBRILLATION; QUINIDINE; SYNCOPE

Mesh:

Substances:

Year:  1963        PMID: 13982509     DOI: 10.1001/archinte.1963.03620260044008

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  11 in total

1.  CONVERSION OF ATRIAL FIBRILLATION BY DIRECT CURRENT COUNTER SHOCK.

Authors:  J F PANTRIDGE; P B HALMOS
Journal:  Br Heart J       Date:  1965-01

2.  LIGHT HALOTHANE ANAESTHESIA WITHOUT MUSCLE RELAXANTS FOR ATRIAL DEFIBRILLATION BY EXTERNAL DIRECT-CURRENT SHOCKS.

Authors:  A MCCLISH; J P DESPRES; J P DECHENE
Journal:  Can Anaesth Soc J       Date:  1965-05

3.  QUINIDINE-INDUCED SYNCOPE.

Authors:  P DAVIES; D LEAK; S ORAM
Journal:  Br Med J       Date:  1965-08-28

Review 4.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

5.  Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine.

Authors:  J I Hall; D R Wood
Journal:  Br Heart J       Date:  1968-01

6.  Appraisal of electroconversion in treatment of cardiac dysrhythmias.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1968-11

7.  [Electrotherapy of arrhythmia. Hemodynamic studies and electric treatment of atrial fibrillation, atrial flutter and disturbances of atrioventricular conduction].

Authors:  W Hager
Journal:  Arch Kreislaufforsch       Date:  1969 May-Jun

8.  Quinidine-induced paroxysmal ventricular fibrillation treated with propranolol.

Authors:  A Seaton
Journal:  Br Med J       Date:  1966-06-18

9.  Direct current conversion of atrial fibrillation.

Authors:  P B Halmos
Journal:  Br Heart J       Date:  1966-05

Review 10.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.